1-2 of 2
Patrick F. Fogarty
Close
Sort by
Journal Articles

Biological Rationale for New Drugs in the Bleeding Disorders Pipeline

Patrick F. Fogarty
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 397–404.
https://doi.org/10.1182/asheducation-2011.1.397
Published: 2011
Journal Articles

What is the Evidence for the Use of Immunomodulatory Agents to Eradicate Inhibitory Antibodies in Patients with Severe Hemophilia A Who Have Previously Failed to Respond to Immune Tolerance Induction?

Michael U. Callaghan, Patrick F. Fogarty
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 405–406.
https://doi.org/10.1182/asheducation-2011.1.405
Published: 2011